Antitrust Considerations for the Pharmaceutical Industry: Pharmacy Benefit Managers (PBMs) and Algorithmic Pricing

Alex Russell filmed a video with Thomson Reuters/PLI, which discusses key trends in antitrust litigation in the pharmaceutical industry. It includes a discussion of the role of algorithmic pricing in recent antitrust claims involving pharmacy benefit managers (PBMs) and provides practical tips for companies involved in the pharmaceutical industry to help navigate and proactively address antitrust risks involving information sharing and pricing algorithms. 

To watch a recording of this speaking engagement, please follow this link.